These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36760155)

  • 21. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
    Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM
    Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Practices in Pharmacogenomics.
    Ramsey LB; Prows CA; Tang Girdwood S; Van Driest S
    Pediatr Clin North Am; 2023 Oct; 70(5):995-1011. PubMed ID: 37704356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review.
    B Tata E; A Ambele M; S Pepper M
    Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32858798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Clinical Relevance of Differences in Allele Frequencies Found within Very Important Pharmacogenes between Hmong and East Asian Populations.
    Wen YF; Culhane-Pera KA; Thyagarajan B; Bishop JR; Zierhut H; Lo M; Xiong T; Peng K; Holzer K; Lee K; Straka RJ
    Pharmacotherapy; 2020 Feb; 40(2):142-152. PubMed ID: 31884695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal pharmacogenomics: A promising addition to complex neonatal care.
    Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
    Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
    Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial Stewardship in Cystic Fibrosis.
    Lloyd EC; Cogen JD; Maples H; Bell SC; Saiman L
    J Pediatric Infect Dis Soc; 2022 Sep; 11(Supplement_2):S53-S61. PubMed ID: 36069899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.
    Hellwig LD; Turner C; Olsen C; Libbus J; Markos B; Koehlmoos T; Haigney M; De Castro M; Saunders D
    Mil Med; 2024 Jan; 189(1-2):e198-e204. PubMed ID: 37436924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
    Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
    Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
    [No Abstract]   [Full Text] [Related]  

  • 30. Integrating pharmacogenomics into precision pain management.
    Bates J; Fudin J; Patel JN
    Support Care Cancer; 2022 Dec; 30(12):10453-10459. PubMed ID: 36271058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 32. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
    Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nebuliser systems for drug delivery in cystic fibrosis.
    Stanford G; Morrison L; Brown C
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007639. PubMed ID: 37942828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis.
    McElvaney OJ; Heltshe SL; Odem-Davis K; West NE; Sanders DB; Fogarty B; VanDevanter DR; Flume PA; Goss CH;
    J Cyst Fibros; 2023 Sep; 22(5):875-879. PubMed ID: 37407341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics in drug regulation: promise, potential and pitfalls.
    Shah RR
    Philos Trans R Soc Lond B Biol Sci; 2005 Aug; 360(1460):1617-38. PubMed ID: 16096112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands.
    Bank PCD; Swen JJ; Guchelaar HJ
    BMC Med; 2019 Jun; 17(1):110. PubMed ID: 31196067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis.
    Reid P; Danahey K; Lopez Velazquez M; Ratain MJ; O'Donnell PH
    Clin Exp Rheumatol; 2021; 39(6):1385-1393. PubMed ID: 33506753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.
    Dong OM; Li A; Suzuki O; Oni-Orisan A; Gonzalez R; Stouffer GA; Lee CR; Wiltshire T
    Pharmacogenomics; 2018 Jun; 19(9):771-782. PubMed ID: 29793377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients dispensed medications with actionable pharmacogenomic biomarkers: rates and characteristics.
    Liu D; Olson KL; Manzi SF; Mandl KD
    Genet Med; 2021 Apr; 23(4):782-786. PubMed ID: 33420348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
    Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
    Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.